Abivax S.A. (ABVX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
ABIVAX (ABVX) ilg'or immun terapiyalarini ishlab chiqishga ixtisoslashgan. Aktivning bozor qiymati dinamikasi ma'lumotlarning yuqori shaffofligini saqlagan holda, yakuniy bosqichdagi sinovlar uchun investitsiyalarni jalb qilishga bo'lgan rahbariyat qobiliyatini tasdiqlaydi. Biznes hozirda birlamchi tahlil xarajatlarini kamaytirish uchun avtomatlashtirilgan molekulyar skriningni joriy etmoqda. Daromadlar yallig'lanishli ichak kasalliklari terapiyalarining davlat xaridlari bilan bog'liq va ushbu ko'rsatkich 0.00 darajasida turibdi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_ABVX_-_ABIVAX_-_Long-Term-Debt-to-Capital "ABVX: ABIVAX Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 30.10.2026 | 👁️GURU.Markets👁️")
Abivax S.A. (ABVX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati ABIVAX|ABVX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Abivax Pharma|ABVX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Abivax SA|ABVX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Abivax|Tezkor likvidlik ko‘rsatkichi abivax.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:ABIVAX - ABVX
ABIVAX (ABVX) kompaniyasining patent portfelini rivojlantirishi va biotexnologiya sohasida yetakchilik uchun kurashi uzoq muddatli qarz moliyaviy leveraj koeffitsiyentida aks etgan. Bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbati kompaniyaning qarz kapitaliga bog'liqlik darajasini belgilaydi, bu esa investorlarga agressiv infratuzilmani kengaytirish va tashqi zarbalar paytida moliyaviy barqarorlikni yo'qotish xavfi o'rtasidagi muvozanatni baholash imkonini beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ADMA (ADMA Corp) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PTGX (Protagonist Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati immunovant.com IMVT|KNSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biocryst.com|Uzoq muddatli qarzning o'z kapitaliga nisbati VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Pieris Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati|SVRA - Uzoq muddatli qarzning kapitalga nisbati|RIGL: Uzoq muddatli qarzning kapitalga nisbati|ANAB (anaptysbio.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|enGene Holdings Inc (ENGN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT (RAPT Therapeutics, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati JBIO (aerovatetx.com)|Uzoq muddatli qarzning kapitalga nisbati ACRS (Aclaris Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati kyvernatx.com KYTX|TLSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA (Cabaletta Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Theratechnologies, Inc (THTX) - Uzoq muddatli qarzning kapitalga nisbati|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ELDN|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati CLYM (Climb Bio Inc.)|Zura Bio Limited - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATYR: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati IMA|STTK: Uzoq muddatli qarzning kapitalga nisbati|Equillium - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX (inflarx.de) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|INMB - Uzoq muddatli qarzning kapitalga nisbati|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Akari Therapeutics PLC (AKTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Aptevo APVO|Uzoq muddatli qarzning kapitalga nisbati AIM|Uzoq muddatli qarzning kapitalga nisbati aditxt.com (ADTX)|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|XORTX Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revbiosciences.com REVB|INDP (Indaptus Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SCNI (Scinai Immunotherapeutics Ltd) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati ALLK (Allakos Inc.)|hookipapharma.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|TCBP: Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD (Third Harmonic Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati